Tick saliva protein fraction inhibits breast cancer by decreasing cell viability and promoting apoptosis in vitro
PLOS One · 2025
DOI: 10.1371/journal.pone.0331779 ↗Kurz gefasst
Fachartikel in der Zeitschrift PLOS One, 2025. Verfasst von Ana Carolina Prado Sousa und 5 weiteren Autor:innen. Beteiligte Einrichtung: Ixodologia Laboratory, Faculty of Veterinary Medicine, Federal University of Uberlandia, Campus Umuarama, Uberlândia, Minas Gerais, Brazil. Hauptthemen laut MEDLINE: Apoptosis, Breast Neoplasms, Saliva, Salivary Proteins and Peptides. Die Arbeit nennt 48 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Tick saliva contains protein and non-protein bioactive molecules with potential therapeutic applications, including anticancer properties. In this study, the effects of protein and non-protein fractions of saliva from different tick species ( Amblyomma spp. and Rhipicephalus sanguineus ) at various concentrations (0.1–10 µg/mL) were tested on the viability, apoptosis, and necrosis of epithelial MDA-MB-231 breast cancer cells and spontaneously immortalized HaCaT cell control. Chemical composition of tick saliva from A. parvum and A. sculptum was characterized by proteomics analysis. Cell viability was assessed using a calcein-based fluorescence method. Hoechst staining quantified the total number of cells per well, while apoptosis and necrosis were evaluated using Hoescht and propidium iodide assays, respectively. On MDA-MB-231 cancer cells, the protein fraction from A. parvum and R. sanguineus significantly reduced cell viability at the highest concentration (10 µg/mL), whereas A. sculptum and non-protein fractions showed no significant effect. Hoechst staining revealed a significant reduction in cell attachment at 10 µg/mL for A. parvum and R. sanguineus . A modest apoptosis (3–8%) was induced by the protein fractions at concentrations as low as 0.1 µg/mL for R. sanguineus and 10 µg/mL for the non-protein fraction of A. sculptum . Necrosis was not observed, except for a slight increase (1%) with the protein fraction of R. sanguineus at 10 µg/mL. No effect of A. americanum tick saliva protein and non-protein fractions was observed in HaCaT control cells. The results of highly represented proteins identified in Amblyomma spp. correlated with effect of tick saliva protein fraction on cancer cells, highlighting the potential anticancer properties of tick saliva protein fraction, which can induce apoptosis and inhibit cell attachment in breast cancer cells. These findings provide a basis for future studies of tick saliva components as novel therapeutic agents and identifying active biomolecules and mechanisms of action.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Ixodologia Laboratory, Faculty of Veterinary Medicine, Federal University of Uberlandia, Campus Umuarama, Uberlândia, Minas Gerais, Brazil.
- Oxidative Stress and Neurodegeneration Group, Medical Sciences Department, Medical School, UCLM, Regional Centre for Biomedical Research, Research Institute of Castilla-La Mancha (IDISCAM), University of Castilla-La Man…
- Department of Medical Sciences, School of Medicine at Ciudad Real, University of Castilla-La Mancha, Ciudad Real, Spain.
- SaBio. Instituto de Investigación en Recursos Cinegéticos IREC-CSIC-UCLM-JCCM, Ciudad Real, Spain.
- Biochemistry Section, Department of Inorganic, Organic Chemistry and Biochemistry, Faculty of Sciences and Chemical Technologies, Universidad de Castilla-La Mancha, Ciudad Real, Spain.
- Department of Veterinary Pathobiology, Center for Veterinary Health Sciences, Oklahoma State University, Stillwater, Oklahoma, United States of America.
ORCID-Profile: Almudena González-García, José de la Fuente
Zitieren
APA
Prado Sousa, A. C., Durán-Prado, M., Villar, M., González-García, A., Szabó, M. P. J., & de la Fuente, J. (2025). Tick saliva protein fraction inhibits breast cancer by decreasing cell viability and promoting apoptosis in vitro. PLOS One. https://doi.org/10.1371/journal.pone.0331779
Vancouver
Prado Sousa AC, Durán-Prado M, Villar M, González-García A, Szabó MPJ, de la Fuente J. Tick saliva protein fraction inhibits breast cancer by decreasing cell viability and promoting apoptosis in vitro. PLOS One. 2025. doi:10.1371/journal.pone.0331779
BibTeX
@article{PradoSousa2025,
author = {Prado Sousa, Ana Carolina and Durán-Prado, Mario and Villar, Margarita and González-García, Almudena and Szabó, Matias Pablo Juan and de la Fuente, José},
title = {Tick saliva protein fraction inhibits breast cancer by decreasing cell viability and promoting apoptosis in vitro},
journal = {PLOS One},
year = {2025},
doi = {10.1371/journal.pone.0331779}
}
EUVIMED